Status:

COMPLETED

Rate of Cancer of Granular Mixed Laterally Spreading Tumors (GM-LST)

Lead Sponsor:

Istituto Clinico Humanitas

Conditions:

Colorectal Cancer

Eligibility:

All Genders

18+ years

Brief Summary

Colorectal cancer (CRC) is the third most common cancer in men and the second in women worldwide, with 1.65 million new cases and almost 835,000 deaths in 2015. CRC is still a major cause of mortality...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • LST-GM defined according to Paris classification
  • Agree to receive follow up phone calls

Exclusion

  • Evidence of familial adenomatous polyposis or inflammatory bowel diseases
  • Deep submucosal invasion diagnosed by distorted pit pattern (Kudo's type V)
  • Poor general clinical condition (American Society of Anesthesiologists score ≥3)
  • Coagulation disorders
  • Pregnancy and breastfeeding

Key Trial Info

Start Date :

December 31 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 31 2020

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT03836131

Start Date

December 31 2018

End Date

January 31 2020

Last Update

February 12 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Humanitas Research Hospital

Milan, Italy, 20089

2

Humanitas Research Hospital

Rozzano, Italy, 20089

Rate of Cancer of Granular Mixed Laterally Spreading Tumors (GM-LST) | DecenTrialz